World's Best Scientists 2026 revealed!
Irene M. Ghobrial

Irene M. Ghobrial

D-Index & Metrics

Medicine

D-Index
106
Citations
50883
World Ranking
6428
National Ranking
3422

Irene M. Ghobrial publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Irene M. Ghobrial sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 779 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Irene M. Ghobrial D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Irene M. Ghobrial sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Irene M. Ghobrial is affiliated with Harvard University in the United States. Their research spans several interconnected fields, focusing primarily on medicine and biochemistry, genetics, and molecular biology. The core areas of study include hematology, molecular biology, oncology, cancer research, and genetics.

The scientist's work addresses various topics, with notable emphasis on multiple myeloma research and treatments, protein degradation and inhibitors, cancer genomics and diagnostics, CAR-T cell therapy research, chronic lymphocytic leukemia research, cancer treatment and pharmacology, and chemokine receptors and signaling.

Recent significant publications by Irene M. Ghobrial include:

  • Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study, 2020, The Lancet Public Health
  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Bone marrow niches in haematological malignancies, 2020, Nature Reviews. Cancer
  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma, 2022, New England Journal of Medicine
  • Rapid implementation of mobile technology for real-time epidemiology of COVID-19, 2020, Science

Irene M. Ghobrial frequently collaborates with a range of co-authors, including Gad Getz, Romanos Sklavenitis-Pistofidis, Elizabeth D. Lightbody, Omar Nadeem, and Catherine R. Marinac.

Publications are often found in respected journals and venues related to hematology and oncology. The most frequent publication venues include Blood, Clinical Lymphoma Myeloma & Leukemia, Cancer Research, Journal of Clinical Oncology, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • Biological properties of extracellular vesicles and their physiological functions

    María Yáñez-Mó;Pia R.-M. Siljander;Zoraida Andreu;Apolonija Bedina Zavec

  • BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

    Jake E. Delmore;Ghayas C. Issa;Madeleine E. Lemieux;Peter B. Rahl

  • Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.

    Long H. Nguyen;David A. Drew;Mark S. Graham;Amit D. Joshi

  • Targeting apoptosis pathways in cancer therapy.

    Irene M. Ghobrial;Thomas E. Witzig;Alex A. Adjei

  • Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

    Paul G. Richardson;Edie Weller;Sagar Lonial;Andrzej J. Jakubowiak

  • Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

    Steven P. Treon;Christina K. Tripsas;Kirsten Meid;Diane Warren

  • BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression

    Aldo M. Roccaro;Antonio Sacco;Patricia Maiso;Abdel Kareem Azab

  • Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

    Thomas E. Witzig;Susan M. Geyer;Irene Ghobrial;David J. Inwards

  • Mitochondrial metabolism promotes adaptation to proteotoxic stress.

    Peter Tsvetkov;Alexandre Detappe;Kai Cai;Heather R Keys

  • Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

    Yazan Alsayed;Hai Ngo;Judith Runnels;Xavier Leleu

  • Genomic complexity of multiple myeloma and its clinical implications

    Salomon Manier;Karma Z. Salem;Karma Z. Salem;Jihye Park;Jihye Park;Dan A. Landau

  • CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

    Abdel Kareem Azab;Judith M. Runnels;Costas Pitsillides;Anne-Sophie Moreau

  • Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.

    Rao H. Prabhala;Dheeraj Pelluru;Mariateresa Fulciniti;Harsha K. Prabhala

  • MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

    Aldo M. Roccaro;Aldo M. Roccaro;Aldo M. Roccaro;Antonio Sacco;Brian Thompson;Xavier Leleu

  • Targeting the bone marrow microenvironment in multiple myeloma

    Yawara Kawano;Michele Moschetta;Salomon Manier;Siobhan Glavey

  • Bone marrow microenvironment in multiple myeloma progression.

    S. Manier;A. Sacco;X. Leleu;Irene Ghobrial

  • A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.

    T E Witzig;C B Reeder;Betsy R LaPlant;M Gupta

  • Bone marrow niches in haematological malignancies.

    Simón Méndez-Ferrer;Simón Méndez-Ferrer;Simón Méndez-Ferrer;Dominique Bonnet;David P. Steensma;Robert P. Hasserjian

  • Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features

    Abdel Kareem Azab;Jinsong Hu;Phong Quang;Feda Azab

  • Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180

    Steven P. Treon;Leukothea Ioakimidis;Jacob D. Soumerai;Christopher J. Patterson

Frequent Co-Authors

Paul G. Richardson
Paul G. Richardson Harvard University
Xavier Leleu
Xavier Leleu Harvard University
Steven P. Treon
Steven P. Treon Harvard University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Robert L. Schlossman
Robert L. Schlossman Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Constantine S. Mitsiades
Constantine S. Mitsiades Harvard University
Noopur Raje
Noopur Raje Harvard University
Yong Zhang
Yong Zhang Tongji University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your healthcare career options beyond a traditional MD? The field of medicine in the USA offers various alternative pathways and degree programs online. These can help you advance quickly, change specialties, or combine clinical skills with leadership roles.

For aspiring nurses, there are now lpn to rn programs without teas test that remove common entry barriers. Moving up the career ladder can be more straightforward for licensed practical nurses seeking to become registered nurses.

If your interests are in the management side of healthcare, a healthcare administration accelerated degree lets you gain leadership expertise quickly—often through flexible, fully online learning. This helps students fast-track into high-demand roles in healthcare organizations.

Registered nurses considering advanced practice can explore rn to np programs, which allow direct bridging to a nurse practitioner degree. This opens up more independent practice and specialization opportunities.

Finally, a best online nutrition degree offers a flexible path for those interested in wellness, dietetics, and public health nutrition, making a difference in preventative medicine.

Best Scientists Citing Irene M. Ghobrial

Trending Scientists